• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
SAB Biotherapeutics released FY2025 9 Months Earnings on November 14 (EST), Actual Revenue USD 0, Actual EPS USD -0.0228
04:00
SAB Biotherapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 83.33K), actual EPS USD -0.2126 (forecast USD -0.4583)
04:00
Oct22
Smith Analyst Covers Multiple Healthcare Stocks and Gives Strong Buy Rating to SAB Biotherapeutics
10:21
Oct18
Smith focuses on specific healthcare stocks
12:56
Aug8
SAB Biotherapeutics released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD 0.1903
03:00
SAB Biotherapeutics released FY2025 Q2 earnings on August 7, 2025 (EST), actual revenue USD 0 (forecast USD 100K), actual EPS USD 0.749 (forecast USD -0.796)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income 5.338 M, EPS -0.2126

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income 6.966 M, EPS 0.749

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.197 M, EPS -0.5592

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BTTC
6.265
+88.99%
+2.975
PETS
3.285
+85.59%
+1.516
ATPC
0.1190
+75.00%
+0.051
AXIL
8.590
+71.12%
+3.570
BEAT
2.325
+50.00%
+0.780
SMX
214.777
+46.81%
+68.477
DHIL
169.985
+44.69%
+52.505
GEMG
8.980
+41.12%
+2.617
MIGI
8.998
+34.30%
+2.370
VELO
11.455
+33.20%
+2.780
View More